|
G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
increases expression
|
ISO
|
Iron-Dextran Complex results in increased expression of ACSL4 protein
|
CTD |
PMID:38056807 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
[ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; dorsomorphin inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]]; GW 6471 inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]]; Iron-Dextran Complex inhibits the reaction [ADIPOQ protein results in increased expression of and results in increased activity of HMOX1 protein]; tin protoporphyrin IX inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]]; tin protoporphyrin IX promotes the reaction [Iron-Dextran Complex inhibits the reaction [ADIPOQ protein results in increased expression of and results in increased activity of HMOX1 protein]]
|
CTD |
PMID:20709802 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
Iron-Dextran Complex affects the reaction [AHR affects the susceptibility to Tetrachlorodibenzodioxin]
|
CTD |
PMID:9443932 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased phosphorylation of AKT1 protein; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased phosphorylation of AKT1 protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:32828744 PMID:33580994 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO EXP
|
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of BAX protein]; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of BAX protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of BAX protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of BAX protein]; SB 203580 inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of BAX protein] Iron-Dextran Complex results in increased expression of BAX protein chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of BAX protein]
|
CTD |
PMID:33285147 PMID:33393188 PMID:38432408 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
ISO EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein] chrysin inhibits the reaction [Iron-Dextran Complex results in decreased expression of BCL2 protein]
|
CTD |
PMID:33285147 PMID:38432408 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
multiple interactions increases expression
|
ISO
|
[ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; [pirinixic acid results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; Bilirubin promotes the reaction [Iron-Dextran Complex results in increased expression of BCL2L1 protein]
|
CTD |
PMID:20709802 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
decreases expression
|
EXP
|
Iron-Dextran Complex results in decreased expression of BGLAP mRNA
|
CTD |
PMID:29122540 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
G
|
Cacna1c
|
calcium voltage-gated channel subunit alpha1 C
|
multiple interactions affects expression
|
ISO
|
Diltiazem inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]; Nimodipine inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]; Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]
|
CTD |
PMID:27095094 PMID:33285147 |
|
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
|
|
G
|
Casp1
|
caspase 1
|
increases expression multiple interactions
|
EXP
|
Iron-Dextran Complex results in increased expression of CASP1 protein chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP1 protein]
|
CTD |
PMID:38432408 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression
|
ISO EXP
|
[ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CASP3 protein; [pirinixic acid results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; Bilirubin inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; dorsomorphin inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]]; GW 6471 inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]]; tin protoporphyrin IX inhibits the reaction [ADIPOQ protein inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of CASP3 protein; chrysin inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of CASP3 protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of CASP3 protein] 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein]; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein; Arginine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]; U 0126 inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of and results in increased cleavage of CASP3 protein]
|
CTD |
PMID:20709802 PMID:32135237 PMID:32828744 PMID:33285147 PMID:33393188 PMID:33580994 PMID:38432408 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Cat
|
catalase
|
multiple interactions increases activity decreases activity increases expression
|
ISO EXP
|
Iron-Dextran Complex promotes the reaction [Benzoyl Peroxide results in decreased activity of CAT protein]; Iron-Dextran Complex promotes the reaction [cumene hydroperoxide results in decreased activity of CAT protein]; Iron-Dextran Complex promotes the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]; Iron-Dextran Complex promotes the reaction [mezerein results in decreased activity of CAT protein]; Iron-Dextran Complex promotes the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein] Iron-Dextran Complex results in increased activity of CAT protein Iron-Dextran Complex results in decreased activity of CAT protein Iron-Dextran Complex results in increased expression of CAT protein Arginine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]; Cyclosporine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; Edaravone inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in decreased activity of CAT protein; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased activity of CAT protein]
|
CTD |
PMID:12065085 PMID:24120471 PMID:28700905 PMID:32135237 PMID:33580994 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of CHUK protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of CHUK protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of CHUK protein]
|
CTD |
PMID:33285147 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression multiple interactions
|
ISO
|
Iron-Dextran Complex results in increased expression of COL1A1 protein Diltiazem inhibits the reaction [Iron-Dextran Complex results in increased expression of COL1A1 protein]; Nimodipine inhibits the reaction [Iron-Dextran Complex results in increased expression of COL1A1 protein]; Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of COL1A1 protein]
|
CTD |
PMID:27095094 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Ctsk
|
cathepsin K
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CTSK protein; Acetylcysteine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CTSK protein]; Deferoxamine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CTSK protein]
|
CTD |
PMID:38971422 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
G
|
Cyba
|
cytochrome b-245 alpha chain
|
increases expression
|
EXP
|
Iron-Dextran Complex results in increased expression of CYBA protein
|
CTD |
PMID:15086920 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
increases expression
|
EXP
|
Iron-Dextran Complex results in increased expression of CYBB protein
|
CTD |
PMID:28700905 PMID:29990562 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:16,030,596...16,065,065
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions decreases activity
|
ISO
|
Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Iron-Dextran Complex results in decreased activity of CYP1A1 protein
|
CTD |
PMID:9443932 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions decreases activity
|
ISO
|
Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] Iron-Dextran Complex results in decreased activity of CYP1A2 protein
|
CTD |
PMID:9443932 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Ddah2
|
DDAH family member 2, ADMA-independent
|
multiple interactions decreases expression
|
ISO
|
[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine; Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; Arginine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]
|
CTD |
PMID:32135237 |
|
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases phosphorylation
|
EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of FOS protein; bergenin inhibits the reaction [Iron-Dextran Complex results in increased phosphorylation of FOS protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of FOS protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of FOS protein]
|
CTD |
PMID:32828744 PMID:33580994 PMID:36207002 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Fth1
|
ferritin heavy chain 1
|
multiple interactions increases expression
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 mRNA; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 protein; Deferoxamine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 protein]; Deferoxamine inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]; Diltiazem inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]; Nimodipine inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]; Resveratrol inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]; Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of FTH1 protein]
|
CTD |
PMID:27095094 PMID:33285147 PMID:33393188 PMID:34044072 PMID:38971422 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
multiple interactions increases expression
|
EXP
|
chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of GOT1 protein]
|
CTD |
PMID:38432408 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases expression
|
EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of GPT protein; chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of GPT protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of GPT protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of GPT protein]
|
CTD |
PMID:32828744 PMID:33580994 PMID:38432408 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
decreases expression
|
ISO
|
Iron-Dextran Complex results in decreased expression of GPX4 protein
|
CTD |
PMID:38056807 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased activity of GSR protein
|
CTD |
PMID:33393188 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Gstm1
|
glutathione S-transferase mu 1
|
multiple interactions increases expression
|
ISO
|
[Iron-Dextran Complex co-treated with Tetrachlorodibenzodioxin] results in increased expression of GSTM1 protein Iron-Dextran Complex results in increased expression of GSTM1 protein
|
CTD |
PMID:9443932 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
G
|
Hamp
|
hepcidin antimicrobial peptide
|
multiple interactions increases expression
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of HAMP mRNA; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of HAMP protein; Deferoxamine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of HAMP protein]; Diltiazem promotes the reaction [Iron-Dextran Complex results in increased expression of HAMP mRNA]; Nimodipine promotes the reaction [Iron-Dextran Complex results in increased expression of HAMP mRNA]; Verapamil promotes the reaction [Iron-Dextran Complex results in increased expression of HAMP mRNA]
|
CTD |
PMID:27095094 PMID:33393188 PMID:38971422 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression
|
ISO EXP
|
Iron-Dextran Complex inhibits the reaction [ADIPOQ protein results in increased expression of and results in increased activity of HMOX1 protein]; tin protoporphyrin IX promotes the reaction [Iron-Dextran Complex inhibits the reaction [ADIPOQ protein results in increased expression of and results in increased activity of HMOX1 protein]] Iron-Dextran Complex results in increased expression of HMOX1 mRNA; Iron-Dextran Complex results in increased expression of HMOX1 protein
|
CTD |
PMID:20709802 PMID:23525258 PMID:38432408 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL1B protein; bergenin inhibits the reaction [Iron-Dextran Complex results in increased expression of IL1B protein]; chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of IL1B protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL1B protein]
|
CTD |
PMID:32828744 PMID:36207002 PMID:38432408 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
EXP ISO
|
Iron-Dextran Complex results in increased expression of IL6 mRNA; Iron-Dextran Complex results in increased expression of IL6 protein [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL6 protein; chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of IL6 protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL6 protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL6 protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL6 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of IL6 protein]
|
CTD |
PMID:29122540 PMID:32828744 PMID:33285147 PMID:33580994 PMID:38432408 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
EXP ISO
|
Iron-Dextran Complex results in increased phosphorylation of MAPK1 protein [Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK1 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK1 protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:28700905 PMID:33285147 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation multiple interactions
|
EXP ISO
|
Iron-Dextran Complex results in increased phosphorylation of MAPK3 protein [Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK3 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK3 protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:28700905 PMID:33285147 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of MMP9 protein; Acetylcysteine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of MMP9 protein]; Deferoxamine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of MMP9 protein]
|
CTD |
PMID:38971422 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases expression
|
EXP
|
chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of MPO protein]
|
CTD |
PMID:38432408 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression
|
EXP
|
Iron-Dextran Complex results in increased expression of NFE2L2 protein
|
CTD |
PMID:38432408 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of NFKBIA protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of NFKBIA protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:33285147 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions increases expression
|
EXP
|
chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of NLRP3 protein]
|
CTD |
PMID:38432408 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
increases expression
|
EXP
|
Iron-Dextran Complex results in increased expression of NOS2 protein
|
CTD |
PMID:28700905 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Nos3
|
nitric oxide synthase 3
|
multiple interactions decreases phosphorylation
|
EXP ISO
|
Iron-Dextran Complex results in increased expression of and results in increased phosphorylation of NOS3 protein Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein Arginine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]
|
CTD |
PMID:29990562 PMID:32135237 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
G
|
Odc1
|
ornithine decarboxylase 1
|
multiple interactions increases activity
|
ISO
|
Iron-Dextran Complex promotes the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein]; Iron-Dextran Complex promotes the reaction [cumene hydroperoxide results in increased activity of ODC1 protein]; Iron-Dextran Complex promotes the reaction [Hydrogen Peroxide results in increased activity of ODC1 protein]; Iron-Dextran Complex promotes the reaction [mezerein results in increased activity of ODC1 protein]; Iron-Dextran Complex promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein] Iron-Dextran Complex results in increased activity of ODC1 protein
|
CTD |
PMID:12065085 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
EXP
|
[taxifolin co-treated with [Iron-Dextran Complex results in increased abundance of Iron]] results in increased expression of PCNA protein
|
CTD |
PMID:32828744 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
multiple interactions
|
EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of PIK3CA protein; [Iron-Dextran Complex results in increased abundance of Iron] which results in decreased phosphorylation of PIK3CA protein; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of PIK3CA protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased phosphorylation of PIK3CA protein]
|
CTD |
PMID:32828744 PMID:33580994 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions decreases expression
|
EXP
|
bergenin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein]; chrysin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein]
|
CTD |
PMID:36207002 PMID:38432408 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
EXP
|
Iron-Dextran Complex results in increased expression of PTGS2 protein bergenin inhibits the reaction [Iron-Dextran Complex results in increased expression of PTGS2 protein]
|
CTD |
PMID:36207002 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
multiple interactions increases expression
|
EXP
|
chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of PYCARD protein]
|
CTD |
PMID:38432408 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO EXP
|
[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein]; SB 203580 inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein]; U 0126 inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein] [Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein; bergenin inhibits the reaction [Iron-Dextran Complex affects the localization of and results in increased expression of RELA protein]; chrysin inhibits the reaction [Iron-Dextran Complex results in increased localization of and results in increased acetylation of RELA protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which affects the localization of RELA protein]; Iron-Dextran Complex affects the localization of and results in increased expression of RELA protein; Iron-Dextran Complex results in increased localization of and results in increased acetylation of RELA protein
|
CTD |
PMID:33285147 PMID:33580994 PMID:36207002 PMID:38432408 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rho
|
rhodopsin
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of RHO mRNA; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of RHO mRNA]
|
CTD |
PMID:33285147 |
|
NCBI chr 4:148,975,597...148,988,693
Ensembl chr 4:150,653,205...150,658,367
|
|
G
|
Rpe65
|
retinoid isomerohydrolase RPE65
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of RPE65 mRNA; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of RPE65 mRNA]
|
CTD |
PMID:33285147 |
|
NCBI chr 2:251,425,228...251,457,209
Ensembl chr 2:251,425,368...251,457,156
|
|
G
|
Sirt1
|
sirtuin 1
|
multiple interactions decreases expression
|
EXP
|
chrysin inhibits the reaction [Iron-Dextran Complex results in decreased expression of SIRT1 protein]
|
CTD |
PMID:38432408 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Slc11a2
|
solute carrier family 11 member 2
|
multiple interactions increases expression
|
ISO
|
Diltiazem inhibits the reaction [Iron-Dextran Complex results in increased expression of SLC11A2 protein]; Nimodipine inhibits the reaction [Iron-Dextran Complex results in increased expression of SLC11A2 protein]; Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of SLC11A2 protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of SLC11A2 protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of SLC11A2 protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of SLC11A2 protein]
|
CTD |
PMID:27095094 PMID:33285147 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941
|
|
G
|
Slc40a1
|
solute carrier family 40 member 1
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of SLC40A1 mRNA
|
CTD |
PMID:33393188 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
|
|
G
|
Sod1
|
superoxide dismutase 1
|
increases expression
|
EXP
|
Iron-Dextran Complex results in increased expression of SOD1 protein
|
CTD |
PMID:29990562 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sod2
|
superoxide dismutase 2
|
decreases expression
|
EXP
|
Iron-Dextran Complex results in decreased expression of SOD2 protein
|
CTD |
PMID:28700905 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
G
|
Tfr2
|
transferrin receptor 2
|
increases expression
|
ISO
|
Iron-Dextran Complex results in increased expression of TFR2 protein
|
CTD |
PMID:27095094 |
|
NCBI chr12:24,744,450...24,761,413
Ensembl chr12:24,744,450...24,761,413
|
|
G
|
Tfrc
|
transferrin receptor
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TFRC protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TFRC protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TFRC protein]
|
CTD |
PMID:33285147 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases secretion
|
EXP
|
Iron-Dextran Complex results in increased secretion of TGFB1 protein
|
CTD |
PMID:23525258 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNF protein; bergenin inhibits the reaction [Iron-Dextran Complex results in increased expression of TNF protein]; chrysin inhibits the reaction [Iron-Dextran Complex results in increased expression of TNF protein]; Ergothioneine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNF protein]; taxifolin inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNF protein] [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNF protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNF protein]
|
CTD |
PMID:32828744 PMID:33285147 PMID:33580994 PMID:36207002 PMID:38432408 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
decreases expression
|
EXP
|
Iron-Dextran Complex results in decreased expression of TNFRSF11B mRNA
|
CTD |
PMID:29122540 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
G
|
Tnfsf11
|
TNF superfamily member 11
|
increases expression multiple interactions
|
EXP ISO
|
Iron-Dextran Complex results in increased expression of TNFSF11 mRNA [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNFSF11; Acetylcysteine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNFSF11]; Deferoxamine inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TNFSF11]
|
CTD |
PMID:29122540 PMID:38971422 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
G
|
Txnip
|
thioredoxin interacting protein
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP mRNA; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNIP protein
|
CTD |
PMID:33393188 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions
|
ISO
|
[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of TXNRD1 mRNA; [Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of TXNRD1 protein
|
CTD |
PMID:33393188 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
G
|
Urod
|
uroporphyrinogen decarboxylase
|
multiple interactions
|
ISO
|
Iron-Dextran Complex promotes the reaction [Tetrachlorodibenzodioxin results in decreased activity of UROD protein]
|
CTD |
PMID:9443932 |
|
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:135,701,296...135,705,380
|
|